Dive into some
exciting news

SeaStar Medical recognizes that key inflammatory messengers can be transformed. See how we're transforming medicine.

Disruptive thinking from a solutions-oriented organization

SeaStar Medical is a privately held, commercial stage medical therapeutics company headquartered in Denver, Colorado. Our revolutionary Selective Cytopheretic Device (SCD) is in the final stages of clinical testing with an anticipated launch date in the second half of 2021.
For any media inquiries, please contact psconsulting@seastarmed.com

Press Releases

Aethlon Medical, Inc. and SeaStar Medical, Inc. Announce Strategic Joint Cross-Licensing Agreement

Collaboration enables the development of Aethlon’s Hemopurifier in tandem with SeaStar’s cartridges for multiple clinical targets. SAN DIEGO and CARDIFF, Calif., July 1, 2019 /PRNewswire/ — Aethlon Medical, Inc. (Nasdaq: AEMD) and SeaStar Medical, Inc. today announced a cross-licensing agreement to jointly develop their respective medical devices to address the care and management of critically ill patients. Aethlon Medical is developing the Hemopurifier®, a first-in-class blood purification cartridge used to remove a range of different particles from the blood, including cancer promoting exosomes for the treatment of cancers with no adequate alternative therapy and viruses for the treatment of life-threatening viral diseases. SeaStar’s platform of cartridges

Read more >

The SCD is an investigational device and is not currently available for sale. Please check back for further updates on device availability in your region.